2021
DOI: 10.1016/j.arbres.2020.07.024
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and Determinants of COPD in Spain: EPISCAN II

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
71
2
19

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 112 publications
(95 citation statements)
references
References 33 publications
3
71
2
19
Order By: Relevance
“…Second, it is worth mentioning that the number of women included in our population was low. This was because, although we recruited the patients consecutively, COPD is far more prevalent in men than in women in our area [20], resulting in the latter being underrepresented. However, we know that COPD has a different impact on women and that the male/female gap affects various areas of the disease, including inhaled therapies [21][22][23].…”
Section: Discussionmentioning
confidence: 99%
“…Second, it is worth mentioning that the number of women included in our population was low. This was because, although we recruited the patients consecutively, COPD is far more prevalent in men than in women in our area [20], resulting in the latter being underrepresented. However, we know that COPD has a different impact on women and that the male/female gap affects various areas of the disease, including inhaled therapies [21][22][23].…”
Section: Discussionmentioning
confidence: 99%
“…The reason to include only those aged 35 years or over is the very low prevalence of COPD among those aged under this age in Spain. 15 …”
Section: Methodsmentioning
confidence: 99%
“…The reason to include only those aged 35 years or over is the very low prevalence of COPD among those aged under this age in Spain. 15 Our study population includes subjects discharged with a primary diagnosis of ischemic stroke identified with the ICD-10 codes shown in Supplementary Table S1.…”
Section: Study Populationmentioning
confidence: 99%
“…Furthermore, its prevalence, morbidity, and mortality are increasing [2]. According to the most recent prevalence study with clinical measurements conducted in Spain, the overall estimated prevalence of COPD among adults aged 40 years or over was 11.8% (95% confidence interval (CI) 11.2-12.5) [3]. Much of the disease burden and healthcare use in COPD patients is related to the management of their comorbidities.…”
Section: Introductionmentioning
confidence: 99%